Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 22.96 Billion | USD 40.48 Billion | 6.5% | 2023 |
According to the report published by Zion Market Research, the global Peripheral Interventions Market size was valued at USD 22.96 Billion in 2023 and is predicted to reach USD 40.48 Billion by the end of 2032. The market is expected to grow with a CAGR of 6.5% during the forecast period. The report analyzes the global Peripheral Interventions Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Peripheral Interventions industry.
Peripheral interventions are the minimally invasive procedures that are been used to treat deep vein thrombosis, peripheral artery diseases, and other vein diseases that are been caused by plaque buildup in the arteries that leads to legs, arms, head, and intestines. The products used for such minimally invasive procedures include stent systems, guide wires, and balloon dilatation catheters.
The global peripheral interventions market is growing at a lucrative rate. Factors such as an increase in the prevalence of peripheral artery diseases, an increase in healthcare expenditure, growing acceptance of minimally invasive procedures are driving the growth of the global peripheral interventions market. It is been anticipated that in the United States, approximately 8.5 million people are living with peripheral artery disease, thereby affecting around 12 to 20 percent of Americans with the age above 60 years. Peripheral artery disease is also considered to be a major risk factor for stroke and heart attack. Thus, huge investment in the healthcare infrastructure and a rise in government initiatives to lower the rising prevalence of the disease are adding up to adopt peripheral intervention for the treatment of the disease.
The practical advantage of this minimally invasive procedure is that it shortens the length of stay at hospitals, increases patient satisfaction & comfort, minimizes hospital cost, and reduces staff & resource use. All these factors are boosting the growth of the global market. Moreover, an increase in the number of catheterization laboratories and favorable medical reimbursement policies are also some of the key features that are spurring the growth of the market. Furthermore, advancements in the technologies for the development of efficient products and devices may create numerous opportunities for the growth of the global peripheral interventions market during the forecast period. However, huge investment costs related to the products and devices used may hinder the growth of the global peripheral interventions market.
The global peripheral interventions market is been affected by the outbreak of Covid-19. The rapidly spreading coronavirus has infected millions of people across the world and has put healthcare professionals under immense pressure. Treatment of the Covid-19 patients is been kept on priority. Other cases and procedures except for the one with an emergency are been postponed. In addition to this, with the fear of getting infected, stay-at-home orders, and social distancing policies the patients preferred online consultation and avoid a visit to hospitals & clinics. All these factors ultimately hampered the growth of the overall market growth. However, as the impact of the pandemic unfolds, the market growth will keep up its pace.
The global peripheral interventions market is segregated based on the application, product, end-use, and region.
Based on the application, the global peripheral interventions market is bifurcated into venous thromboembolism, peripheral artery disease, and others.
Based on the product, the global market is divided into IVC filters, embolic devices, guide wires, sheath, thrombectomy devices, atherectomy devices, stents, catheters, and others.
The end-use segment is split into ambulatory surgical centers, catheterization laboratories, hospitals, and others.
Report Attributes | Report Details |
---|---|
Report Name | Peripheral Interventions Market |
Market Size in 2023 | USD 22.96 Billion |
Market Forecast in 2032 | USD 40.48 Billion |
Growth Rate | CAGR of 6.5% |
Number of Pages | 199 |
Key Companies Covered | Meril Life Sciences, Becton Dickinson and Company, Boston Scientific Corporation, AngioDynamics Inc., Medtronic, Cardinal Health, B. Braun, Abbott Laboratories, Terumo Interventional Systems, and Depuy Synthesis |
Segments Covered | By application, By product, By end-use and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
In terms of revenue, North America is projected to account for the maximum share in the global peripheral interventions market over the forecast period. The presence of state-of-the-art healthcare infrastructure, rapid adoption of advanced technologies for the treatment of diseases, favorable reimbursement policies, and increase in the prevalence of periphery artery diseases are some of the factors that are fueling the growth of the market in this region. Europe is anticipated to hold the second rank. This is attributable to the rise in investment in the development of peripheral intervention products. On the other hand, Asia Pacific is estimated to grow at a rapid pace due to the rise in the economic growth, increase in healthcare expenditure, and growing adoption of minimally invasive procedures.
The nature of the global peripheral interventions market is highly competitive. The key players operating in the global peripheral interventions market are
By Application
By Product
By end-use
FrequentlyAsked Questions
The global peripheral interventions market is growing at a lucrative rate. Factors such as an increase in the prevalence of peripheral artery diseases, an increase in healthcare expenditure, growing acceptance of minimally invasive procedures are driving the growth of the global peripheral interventions market. Furthermore, advancements in the technologies for the development of efficient products and devices may create numerous opportunities for the growth of the global peripheral interventions market during the forecast period.
The nature of the global peripheral interventions market is highly competitive. The key players operating in the global peripheral interventions market are Meril Life Sciences, Becton Dickinson and Company, Boston Scientific Corporation, AngioDynamics Inc., Medtronic, Cardinal Health, B. Braun, Abbott Laboratories, Terumo Interventional Systems, and Depuy Synthesis.
In terms of revenue, North America is projected to account for the maximum share in the global peripheral interventions market over the forecast period. The presence of state-of-the-art healthcare infrastructure, rapid adoption of advanced technologies for the treatment of diseases, favorable reimbursement policies, and increase in the prevalence of periphery artery diseases are some of the factors that are fueling the growth of the market in this region.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed